• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Effect of Immunosuppression on Th2 and B-cell Responses to Influenza Vaccination

tetano

Editor, Senior Moderator
J Infect Dis. 2015 Jan 14. pii: jiv015. [Epub ahead of print]
[h=1]Effect of Immunosuppression on Th2 and B-cell Responses to Influenza Vaccination.[/h] Egli A[SUP]1[/SUP], Humar A[SUP]2[/SUP], Widmer LA[SUP]3[/SUP], Lisboa LF[SUP]4[/SUP], Santer DM[SUP]4[/SUP], Mueller T[SUP]5[/SUP], Stelling J[SUP]3[/SUP], Baluch A[SUP]6[/SUP], O'Shea D[SUP]4[/SUP], Houghton M[SUP]4[/SUP], Kumar D[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h]  Influenza vaccine immunogenicity is suboptimal in immunocompromised patients. However, there are limited data on the interplay of T- and B- cell responses to vaccination with simultaneous immunosuppression.
[h=4]METHODS:[/h]  We collected peripheral blood mononuclear cells from transplant recipients pre and one-month post seasonal influenza vaccination. Pre- and post-vaccination, H1N1-specific T- and B-cell activation were quantified using flow cytometry. We further developed a mathematical model using T- and B-cell markers, and mycophenolate mofetil (MMF) dosage.
[h=4]RESULTS:[/h]   In the 47 patients analyzed, seroconversion to H1N1-antigen was 34%. H1N1-specific IL-4-producing CD4+ T-cell frequencies significantly increased after vaccination in 53% of the patients. Pre-vaccination expression of H1N1-induced HLA-DR and CD86 on B-cells was high in patients that seroconverted. Seroconversion against H1N1 was strongly associated with HLA-DR-expression on B-cells, which was dependent on the increase of H1N1-specific IL-4+CD4+ T-cells pre-to-post vaccine (R[SUP]2[/SUP]=0.35). High doses of MMF ≥2g/d led to lower seroconversion rates, lower increase of H1N1-specific IL-4+CD4+ T-cells and reduced HLA-DR-expression on B-cells. The mathematical model incorporating a MMF-inhibited positive feedback loop between H1N1-specific IL-4+CD4+ T-cells and HLA-DR-expression on B-cells captured seroconversion with high specificity.
[h=4]CONCLUSIONS:[/h]  Seroconversion is associated with influenza-specific Th2 and B-cell activation and appears to be modulated by MMF.
? The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.


PMID: 25589334 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25589334
 
Back
Top Bottom